Jain RK - Search Results

1

Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.

Emblem KE, Farrar CT, Gerstner ER, Batchelor TT, Borra RJ, Rosen BR, Sorensen AG, Jain RK. Emblem KE, et al. Among authors: jain rk. Nat Rev Clin Oncol. 2014 Oct;11(10):566-84. doi: 10.1038/nrclinonc.2014.126. Epub 2014 Aug 12. Nat Rev Clin Oncol. 2014. PMID: 25113840 Free PMC article. Review.

2

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Jain RK. Jain RK. Nat Med. 2001 Sep;7(9):987-9. doi: 10.1038/nm0901-987. Nat Med. 2001. PMID: 11533692 Review. No abstract available.

3

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

Izumi Y, Xu L, di Tomaso E, Fukumura D, Jain RK. Izumi Y, et al. Among authors: jain rk. Nature. 2002 Mar 21;416(6878):279-80. doi: 10.1038/416279b. Nature. 2002. PMID: 11907566

4

Dissecting tumour pathophysiology using intravital microscopy.

Jain RK, Munn LL, Fukumura D. Jain RK, et al. Nat Rev Cancer. 2002 Apr;2(4):266-76. doi: 10.1038/nrc778. Nat Rev Cancer. 2002. PMID: 12001988 Review.

5

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.

Jain RK. Jain RK. Semin Oncol. 2002 Dec;29(6 Suppl 16):3-9. doi: 10.1053/sonc.2002.37265. Semin Oncol. 2002. PMID: 12516032 Review.

6

Molecular regulation of vessel maturation.

Jain RK. Jain RK. Nat Med. 2003 Jun;9(6):685-93. doi: 10.1038/nm0603-685. Nat Med. 2003. PMID: 12778167 Review.

7

Pathology: cancer cells compress intratumour vessels.

Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK. Padera TP, et al. Among authors: jain rk. Nature. 2004 Feb 19;427(6976):695. doi: 10.1038/427695a. Nature. 2004. PMID: 14973470

8

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.

Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH, Jain RK. Garkavtsev I, et al. Among authors: jain rk. Nature. 2004 Mar 18;428(6980):328-32. doi: 10.1038/nature02329. Nature. 2004. PMID: 15029197

9

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Jain RK. Jain RK. Science. 2005 Jan 7;307(5706):58-62. doi: 10.1126/science.1104819. Science. 2005. PMID: 15637262 Review.

10

Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

Jain RK, Duda DG, Clark JW, Loeffler JS. Jain RK, et al. Nat Clin Pract Oncol. 2006 Jan;3(1):24-40. doi: 10.1038/ncponc0403. Nat Clin Pract Oncol. 2006. PMID: 16407877 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,367 results

Search Page